Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Case report of Plasmodium ovale curtisi malaria in Sri Lanka: relevance for the maintenance of elimination status.

Gunawardena S, Daniels RF, Yahathugoda TC, Weerasooriya MV, Durfee K, Volkman SK, Wirth DF, Karunaweera ND.

BMC Infect Dis. 2017 Apr 24;17(1):307. doi: 10.1186/s12879-017-2411-z.

2.

Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.

Gunawardena S, Kapilananda GM, Samarakoon D, Maddevithana S, Wijesundera S, Goonaratne LV, Karunaweera ND.

PLoS One. 2017 Feb 2;12(2):e0171208. doi: 10.1371/journal.pone.0171208. eCollection 2017.

3.

In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.

Manamperi NH, Oghumu S, Pathirana N, de Silva MV, Abeyewickreme W, Satoskar AR, Karunaweera ND.

Parasite Immunol. 2017 Mar;39(3). doi: 10.1111/pim.12413.

PMID:
28112425
4.

Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.

Dewasurendra RL, Dias JN, Sepulveda N, Gunawardena GS, Chandrasekharan N, Drakeley C, Karunaweera ND.

BMC Infect Dis. 2017 Jan 9;17(1):49. doi: 10.1186/s12879-016-2164-0.

5.

Nonresponsiveness to standard treatment in cutaneous leishmaniasis: A case series from Sri Lanka.

Refai FW, Madarasingha NP, Fernandopulle R, Karunaweera N.

Trop Parasitol. 2016 Jul-Dec;6(2):155-158.

6.

Loop-mediated isothermal amplification assay as a sensitive diagnostic tool for Leishmania donovani infections in Sri Lanka.

Kothalawala HS, Karunaweera ND.

Ceylon Med J. 2016 Jun;61(2):68-70. doi: 10.4038/cmj.v61i2.8286.

7.

Genomic analysis of local variation and recent evolution in Plasmodium vivax.

Pearson RD, Amato R, Auburn S, Miotto O, Almagro-Garcia J, Amaratunga C, Suon S, Mao S, Noviyanti R, Trimarsanto H, Marfurt J, Anstey NM, William T, Boni MF, Dolecek C, Tran HT, White NJ, Michon P, Siba P, Tavul L, Harrison G, Barry A, Mueller I, Ferreira MU, Karunaweera N, Randrianarivelojosia M, Gao Q, Hubbart C, Hart L, Jeffery B, Drury E, Mead D, Kekre M, Campino S, Manske M, Cornelius VJ, MacInnis B, Rockett KA, Miles A, Rayner JC, Fairhurst RM, Nosten F, Price RN, Kwiatkowski DP.

Nat Genet. 2016 Aug;48(8):959-64. doi: 10.1038/ng.3599. Epub 2016 Jun 27.

8.

Admixture into and within sub-Saharan Africa.

Busby GB, Band G, Si Le Q, Jallow M, Bougama E, Mangano VD, Amenga-Etego LN, Enimil A, Apinjoh T, Ndila CM, Manjurano A, Nyirongo V, Doumba O, Rockett KA, Kwiatkowski DP, Spencer CC; Malaria Genomic Epidemiology Network.

Elife. 2016 Jun 21;5. pii: e15266. doi: 10.7554/eLife.15266.

9.

Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review.

Samaranayake N, Fernando SD, Neththikumara NF, Rodrigo C, Karunaweera ND, Dissanayake VH.

BMC Infect Dis. 2016 Jun 14;16:292. doi: 10.1186/s12879-016-1626-8.

10.

Leishmaniasis: Path toward elimination from the Indian subcontinent.

Karunaweera ND.

Trop Parasitol. 2016 Jan-Jun;6(1):2-4. doi: 10.4103/2229-5070.175023. No abstract available.

11.

Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.

Uyoga S, Ndila CM, Macharia AW, Nyutu G, Shah S, Peshu N, Clarke GM, Kwiatkowski DP, Rockett KA, Williams TN; MalariaGEN Consortium.

Lancet Haematol. 2015 Oct;2(10):e437-44. doi: 10.1016/S2352-3026(15)00152-0. Epub 2015 Sep 22.

12.

Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.

Steiner N, Balez R, Karunaweera N, Lind JM, Münch G, Ooi L.

Neurochem Int. 2016 May;95:46-54. doi: 10.1016/j.neuint.2015.10.013. Epub 2015 Oct 29.

13.

Characterisation of cutaneous leishmaniasis in Matara district, southern Sri Lanka: evidence for case clustering.

Kariyawasam KK, Edirisuriya CS, Senerath U, Hensmen D, Siriwardana HV, Karunaweera ND.

Pathog Glob Health. 2015;109(7):336-43. doi: 10.1179/2047773215Y.0000000032. Epub 2015 Sep 7.

14.

Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.

Shelton JM, Corran P, Risley P, Silva N, Hubbart C, Jeffreys A, Rowlands K, Craik R, Cornelius V, Hensmann M, Molloy S, Sepulveda N, Clark TG, Band G, Clarke GM, Spencer CC, Kerasidou A, Campino S, Auburn S, Tall A, Ly AB, Mercereau-Puijalon O, Sakuntabhai A, Djimdé A, Maiga B, Touré O, Doumbo OK, Dolo A, Troye-Blomberg M, Mangano VD, Verra F, Modiano D, Bougouma E, Sirima SB, Ibrahim M, Hussain A, Eid N, Elzein A, Mohammed H, Elhassan A, Elhassan I, Williams TN, Ndila C, Macharia A, Marsh K, Manjurano A, Reyburn H, Lemnge M, Ishengoma D, Carter R, Karunaweera N, Fernando D, Dewasurendra R, Drakeley CJ, Riley EM, Kwiatkowski DP, Rockett KA; MalariaGEN Consortium.

Malar J. 2015 Aug 28;14:333. doi: 10.1186/s12936-015-0833-x.

15.

Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka.

Siriwardana HV, Senarath U, Chandrawansa PH, Karunaweera ND.

Pathog Glob Health. 2015 Jun;109(4):174-83. doi: 10.1179/2047773215Y.0000000024. Epub 2015 Jul 16.

16.

Plant polyphenols as inhibitors of NF-κB induced cytokine production-a potential anti-inflammatory treatment for Alzheimer's disease?

Karunaweera N, Raju R, Gyengesi E, Münch G.

Front Mol Neurosci. 2015 Jun 16;8:24. doi: 10.3389/fnmol.2015.00024. eCollection 2015. No abstract available.

17.

Plasmodium vivax Diversity and Population Structure across Four Continents.

Koepfli C, Rodrigues PT, Antao T, Orjuela-Sánchez P, Van den Eede P, Gamboa D, van Hong N, Bendezu J, Erhart A, Barnadas C, Ratsimbasoa A, Menard D, Severini C, Menegon M, Nour BY, Karunaweera N, Mueller I, Ferreira MU, Felger I.

PLoS Negl Trop Dis. 2015 Jun 30;9(6):e0003872. doi: 10.1371/journal.pntd.0003872. eCollection 2015.

18.

Advances in genetics and genomics: use and limitations in achieving malaria elimination goals.

Gunawardena S, Karunaweera ND.

Pathog Glob Health. 2015 May;109(3):123-41. doi: 10.1179/2047773215Y.0000000015. Review.

19.

G6PD gene variants and its association with malaria in a Sri Lankan population.

Dewasurendra RL, Rockett KA, Fernando SD, Carter R, Kwiatkowski DP, Karunaweera ND; MalariaGEN Consortium.

Malar J. 2015 Feb 22;14:93. doi: 10.1186/s12936-015-0603-9.

20.

Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections.

Baniecki ML, Faust AL, Schaffner SF, Park DJ, Galinsky K, Daniels RF, Hamilton E, Ferreira MU, Karunaweera ND, Serre D, Zimmerman PA, Sá JM, Wellems TE, Musset L, Legrand E, Melnikov A, Neafsey DE, Volkman SK, Wirth DF, Sabeti PC.

PLoS Negl Trop Dis. 2015 Mar 17;9(3):e0003539. doi: 10.1371/journal.pntd.0003539. eCollection 2015 Mar.

Supplemental Content

Loading ...
Support Center